NicOx is a biomedical company focused in the ophthalmic market. The company is building a diversified portfolio of innovative therapies and diagnostic tools addressing the needs of eyecare practitioners and patients around the world. The company's growth strategy is focused on outstanding international collaborations and on our proprietary nitric oxide-donating research platform.
NicOx is seeking and evaluating commercial and late-stage ophthalmic products as well as potential acquisitions of local ophthalmic companies in Europes largest markets. NicOx has offices in France, Italy, and Texas in the United States.
